These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3299507)
1. Effects of proglumide on pancreatic endocrine and exocrine function in healthy humans. Funakoshi A; Nakano I; Shinozaki H; Miyazaki K; Ibayashi H Regul Pept; 1987 Jun; 17(6):311-8. PubMed ID: 3299507 [TBL] [Abstract][Full Text] [Related]
2. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas. Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254 [TBL] [Abstract][Full Text] [Related]
3. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep. Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447 [TBL] [Abstract][Full Text] [Related]
4. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog. Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149 [TBL] [Abstract][Full Text] [Related]
5. Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro. Verspohl EJ; Wunderle G; Ammon HP; Williams JA; Goldfine ID Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):284-7. PubMed ID: 3012373 [TBL] [Abstract][Full Text] [Related]
6. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man. Gabryelewicz A; Kulesza E; Konturek SJ Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088 [TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats]. Shiratori K; Watanabe S; Shimizu K; Moriyoshi Y; Chang JH; Takeuchi T Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):70-6. PubMed ID: 2471850 [TBL] [Abstract][Full Text] [Related]
8. Effects of CCK on pancreatic function and morphology. Niederau C; Lüthen R; Heintges T Ann N Y Acad Sci; 1994 Mar; 713():180-98. PubMed ID: 8185159 [TBL] [Abstract][Full Text] [Related]
9. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas. Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557 [TBL] [Abstract][Full Text] [Related]
10. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719 [TBL] [Abstract][Full Text] [Related]
12. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat. Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Digestion; 1989; 42(2):61-9. PubMed ID: 2475379 [TBL] [Abstract][Full Text] [Related]
13. Effect of cholecystokinin receptor antagonist on pancreatic responses to exogenous gastrin and cholecystokinin and to meal stimuli. Konturek SJ; Tasler J; Cieszkowski M; Szewczyk K; Hladij M Gastroenterology; 1988 Apr; 94(4):1014-23. PubMed ID: 3345871 [TBL] [Abstract][Full Text] [Related]
14. Effects of proglumide on pancreatic acinar cell function. Williams JA; Bailey A; Steigerwalt RW Digestion; 1983; 27(4):227-33. PubMed ID: 6197332 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide. Varga G; Papp M; Scarpignato C Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419 [TBL] [Abstract][Full Text] [Related]
16. Effect of chronic oral administration of the CCK receptor antagonist loxiglumide on exocrine and endocrine pancreas in normal rats. Imoto I; Yamamoto M; Jia DM; Otsuki M Int J Pancreatol; 1997 Dec; 22(3):177-85. PubMed ID: 9444548 [TBL] [Abstract][Full Text] [Related]
17. Effect of CCK antagonists CR 1409 and CR 1505 on rat pancreatic exocrine secretion in vivo. Shiratori K; Shimizu K; Watanabe S; Takeuchi T; Moriyoshi Y Pancreas; 1989; 4(6):744-50. PubMed ID: 2813333 [TBL] [Abstract][Full Text] [Related]
18. Comparison of effects of proglumide and CR 1409, a new glutaramic acid derivative, on CCK-8-induced pancreatic polypeptide and insulin secretion in the dog. Inui A; Oya M; Inoue T; Sakatani N; Morioka H; Baba S Horm Metab Res; 1988 Jan; 20(1):61-2. PubMed ID: 3286447 [No Abstract] [Full Text] [Related]
19. Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs. Hildebrand P; Beglinger C; Köhler E; Setnikar I; Gyr K Regul Pept; 1987 Aug; 18(3-4):213-20. PubMed ID: 3446223 [TBL] [Abstract][Full Text] [Related]
20. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans. Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]